The need for a tailored immunosuppression in older heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1965-1968

  Kaczmarek, Ingo ^a,b   Sadoni, Sebastian ^a   Schmoeckel, Michael ^a   Lamm, Peter ^a   Daebritz, Sabine ^a   Veberfuhr, Peter ^a   Meiser, Bruno ^a   Reichart, Bruno ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INFECTION PREVENTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; CARDIAC OUTPUT; CHILD; CREATININE; GRAFT REJECTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 27844569484     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.04.008     Document Type: Article

References (13)

1. A.L. Heroux, M.R. Costanzo-Nordin, J.E. O'Sullivan Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age J Heart Lung Transplant 12 1993 573 578
2. J.E. Everett, A.R. Djalilian, S.H. Kubo, T.J. Kroshus, S.J. Shumway Heart transplantation for patients over age 60 Clin Transplant 10 1996 478 481
3. D. Marelli, H. Laks, J.A. Kobashigawa Seventeen-year experience with 1,083 heart transplants at a single institution Ann Thorac Surg 74 2002 1558 1566
4. A.M. Borkon, G.F. Muehlebach, P.G. Jones An analysis of the effect of age on survival after heart transplantation J Heart Lung Transplant 18 1999 668 674
5. A. Fabbri, L.D. Sharples, P. Mulins, N. Caine, S. Large, J. Wallwork Heart transplantation in patients over 54 years of age with triple-drug immunosuppression J Heart Lung Transplant 11 1992 929 932
6. R.C. Bourge, D.C. Naftel, M.R. Costanzo-Nordin Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group J Heart Lung Transplant 12 1993 549 562
7. D.A. Bull, S.V. Karwande, J.A. Hawkins Long-term results of cardiac transplantation in patients older than 60 years. UTAH Cardiac Transplant Program J Thorac Cardiovasc Surg 111 1996 423 428
8. J.D. Hosenpud, L.E. Bennett, B.M. Keck, M.M. Boucek, R.J. Novick The registry of the International Society for Heart and Lung Transplantation eighteenth official report - 2001 J Heart Lung Transplant 20 2001 805 815
9. D.G. Renlund, E.M. Gilbert, J.B. O'Connell Age-associated decline in cardiac allograft rejection Am J Med 83 1987 391 398
10. B.M. Meiser, M. Pfeiffer, D. Schmidt Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation importance of mycophenolic acid therapeutic drug monitoring J Heart Lung Transplant 18 1999 143 149
11. A.P. Van den Berg, W.N. Twilhaar, W.J. van Son Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis Transplant Int 11 suppl 1 1998 318 321
12. D.A. Baran, I.D. Galin One size fits all immunosuppression in cardiac transplantation Ann Transplant 8 2003 7 9
13. H. Eisen, H. Ross Optimizing the immunosuppressive regimen in heart transplantation J Heart Lung Transplant 23 suppl 5 2004 S207 S213